FEBIX | RIRAX | FEBIX / RIRAX | |
Total Expense Ratio | 0.96 | 1.36 | 71% |
Annual Report Gross Expense Ratio | 0.96 | 1.36 | 71% |
Fund Existence | 13 years | 23 years | - |
Gain YTD | 14.935 | 13.587 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.99B | 117B | 2% |
Annual Yield % from dividends | 2.64 | 2.27 | 116% |
Returns for 1 year | 14.71 | 14.10 | 104% |
Returns for 3 years | 32.90 | 31.57 | 104% |
Returns for 5 years | 44.60 | 45.77 | 97% |
Returns for 10 years | 74.49 | 48.08 | 155% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NEJYX | 21.39 | 0.25 | +1.18% |
Natixis Vaughan Nelson Small Cap Y | |||
DNLCX | 53.80 | 0.36 | +0.67% |
BNY Mellon Active MidCap C | |||
NESIX | 19.90 | 0.07 | +0.35% |
Needham Small Cap Growth Institutional | |||
RDCEX | 15.01 | 0.05 | +0.33% |
Columbia Disciplined Core C | |||
MSVDX | 5.59 | 0.01 | +0.18% |
Morgan Stanley Vitality Portfolio I |